Editas Medicine, Inc.
METHODS OF ASSESSING NUCLEASE CLEAVAGE
Last updated:
Abstract:
The present disclosure relates to methods of analyzing activity of nucleases, such as ZFNs, TALENs or CRISPR-associated nucleases, in particular their cutting at "off-target" loci.
Status:
Application
Type:
Utility
Filling date:
5 Jan 2018
Issue date:
23 Jul 2020